• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一种针对醛氧化酶催化反应的合适且具有选择性的抑制剂。

Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions.

作者信息

Nirogi Ramakrishna, Kandikere Vishwottam, Palacharla Raghava Choudary, Bhyrapuneni Gopinadh, Kanamarlapudi Vijaya Bhargava, Ponnamaneni Ranjith Kumar, Manoharan Arun Kumar

机构信息

Discovery Research and.

出版信息

Xenobiotica. 2014 Mar;44(3):197-204. doi: 10.3109/00498254.2013.819594. Epub 2013 Oct 24.

DOI:10.3109/00498254.2013.819594
PMID:24156774
Abstract

1. Aldehyde oxidase (AO) is a liver cytosolic molybdoflavoprotein enzyme whose importance in drug metabolism is gaining in the recent. The objective of this work is to find a potent and selective inhibitor for AO activity using phthalazine oxidation as a marker reaction. 2. Among organic solvents tested, it was identified that methanol was not a suitable choice for AO activity even at concentrations less than 0.2% v/v. Acetonitrile and DMSO did not show any effect till 0.5% v/v but thereafter activites tend to decrease. 3. For selectivity, 23 compounds were selected and evaluated for their effects on AO and nine CYP450 enzymes. Among the tested compounds chlorpromazine, estradiol, hydralazine, quetiapine and raloxifene were selected based on their potency of inhibition towards AO activity. 4. Raloxifene was found to be a non-specific inhibitor of all major tested CYP450 enzymes and was excluded as a selective inhibitor for AO. Quetiapine also showed a degree of inhibition towards the major CYP450 tested. Hydralazine used as a specific inhibitor during the past for AO activity demonstrated a stimulation of AO activity at high and low concentrations respectively and the inhibition noted to be time dependent while inhibiting other enzymes like monoamine oxidase. 5. Estradiol showed no inhibition towards the tested CYP450 enzymes and thus proved to be a selective and specific inhibitor for AO activity with an uncompetitive mode of inhibition.

摘要
  1. 醛氧化酶(AO)是一种肝脏胞质钼黄素蛋白酶,其在药物代谢中的重要性近年来日益凸显。本研究的目的是利用酞嗪氧化作为标记反应,寻找一种高效且选择性的AO活性抑制剂。2. 在测试的有机溶剂中,已确定即使甲醇浓度低于0.2% v/v,也不是AO活性的合适选择。乙腈和二甲基亚砜在0.5% v/v之前未显示任何影响,但此后活性趋于下降。3. 为了评估选择性,选择了23种化合物并评估它们对AO和9种细胞色素P450酶的影响。在测试的化合物中,根据它们对AO活性的抑制效力,选择了氯丙嗪、雌二醇、肼屈嗪、喹硫平和雷洛昔芬。4. 发现雷洛昔芬是所有主要测试的细胞色素P450酶的非特异性抑制剂,因此被排除作为AO的选择性抑制剂。喹硫平也对主要测试的细胞色素P450表现出一定程度的抑制。过去用作AO活性特异性抑制剂的肼屈嗪,在高浓度和低浓度时分别显示出对AO活性的刺激作用,并且在抑制单胺氧化酶等其他酶时,观察到其抑制作用具有时间依赖性。5. 雌二醇对测试的细胞色素P450酶没有抑制作用,因此被证明是一种具有非竞争性抑制模式的AO活性选择性和特异性抑制剂。

相似文献

1
Identification of a suitable and selective inhibitor towards aldehyde oxidase catalyzed reactions.鉴定一种针对醛氧化酶催化反应的合适且具有选择性的抑制剂。
Xenobiotica. 2014 Mar;44(3):197-204. doi: 10.3109/00498254.2013.819594. Epub 2013 Oct 24.
2
Effect of commonly used organic solvents on aldehyde oxidase-mediated vanillin, phthalazine and methotrexate oxidation in human, rat and mouse liver subcellular fractions.常用有机溶剂对人、大鼠和小鼠肝脏亚细胞组分中醛氧化酶介导的香草醛、酞嗪和甲氨蝶呤氧化的影响。
Xenobiotica. 2014 Aug;44(8):722-33. doi: 10.3109/00498254.2014.889332. Epub 2014 Feb 17.
3
Potent inhibition of human liver aldehyde oxidase by raloxifene.雷洛昔芬对人肝脏醛氧化酶的强效抑制作用。
Drug Metab Dispos. 2004 Jan;32(1):89-97. doi: 10.1124/dmd.32.1.89.
4
Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.肼苯哒嗪作为人肝细胞中醛氧化酶的选择性探针失活剂:估计醛氧化酶对代谢清除率的贡献。
Drug Metab Dispos. 2012 Jul;40(7):1441-8. doi: 10.1124/dmd.112.045195. Epub 2012 Apr 20.
5
Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine.时间依赖性醛氧化酶抑制剂肼屈嗪的作用机制研究。
Drug Metab Dispos. 2023 Jun;51(6):782-791. doi: 10.1124/dmd.123.001257. Epub 2023 Mar 15.
6
Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases.醛氧化酶抑制剂雷洛昔芬对黄嘌呤氧化酶的抑制作用:对鉴定钼蝶呤亚硝酸还原酶的启示。
Nitric Oxide. 2014 Feb 15;37:41-5. doi: 10.1016/j.niox.2013.12.010. Epub 2014 Jan 7.
7
Evaluation of Cytochrome P450 Selectivity for Hydralazine as an Aldehyde Oxidase Inhibitor for Reaction Phenotyping.评价肼屈嗪作为醛氧化酶抑制剂用于反应表型分析的细胞色素 P450 选择性。
J Pharm Sci. 2019 Apr;108(4):1627-1630. doi: 10.1016/j.xphs.2018.11.007. Epub 2018 Nov 15.
8
Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase.人肝醛氧化酶的底物依赖抑制谱的证据。
Drug Metab Dispos. 2013 Jan;41(1):24-9. doi: 10.1124/dmd.112.048546. Epub 2012 Sep 20.
9
Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin.用豚鼠肝脏醛氧化酶和肝切片对酞嗪进行酶促氧化:异香草醛的抑制作用。
Acta Biochim Pol. 2004;51(4):943-51.
10
Human liver aldehyde oxidase: inhibition by 239 drugs.人肝脏醛氧化酶:239种药物对其的抑制作用
J Clin Pharmacol. 2004 Jan;44(1):7-19. doi: 10.1177/0091270003260336.

引用本文的文献

1
Optimization of In Vitro CYP3A4 TDI Assay Conditions and Use of Derived Parameters for Clinical DDI Risk Assessment Using Static and Dynamic Models.使用静态和动态模型优化体外CYP3A4时间依赖性抑制(TDI)试验条件及衍生参数在临床药物相互作用(DDI)风险评估中的应用
AAPS J. 2025 Aug 13;27(5):131. doi: 10.1208/s12248-025-01114-w.
2
Establishing a physiologically based pharmacokinetic framework for aldehyde oxidase and dual aldehyde oxidase-CYP substrates.建立基于生理学的醛氧化酶和双醛氧化酶-CYP底物的药代动力学框架。
CPT Pharmacometrics Syst Pharmacol. 2025 Jan;14(1):164-178. doi: 10.1002/psp4.13255. Epub 2024 Oct 23.
3
Time-restricted feeding ameliorates non-alcoholic fatty liver disease through modulating hepatic nicotinamide metabolism via gut microbiota remodeling.
限时喂养通过调节肠道微生物群重塑来改善肝内烟酰胺代谢,从而改善非酒精性脂肪性肝病。
Gut Microbes. 2024 Jan-Dec;16(1):2390164. doi: 10.1080/19490976.2024.2390164. Epub 2024 Aug 18.
4
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.选定的非 P450 人氧化还原酶在化学品的保护和毒性作用中的作用:反应的综述和汇编。
Arch Toxicol. 2022 Aug;96(8):2145-2246. doi: 10.1007/s00204-022-03304-3. Epub 2022 Jun 1.
5
4-Pyridoxic Acid/Pyridoxine Ratio in Patients with Type 2 Diabetes is Related to Global Cardiovascular Risk Scores.2型糖尿病患者的4-吡哆酸/吡哆醇比值与全球心血管风险评分相关。
Diagnostics (Basel). 2019 Mar 6;9(1):28. doi: 10.3390/diagnostics9010028.
6
Effects of Phenothiazines on Aldehyde Oxidase Activity Towards Aldehydes and N-Heterocycles: an In Vitro and In Silico Study.吩噻嗪类药物对醛氧化酶针对醛类和氮杂环化合物活性的影响:一项体外和计算机模拟研究。
Eur J Drug Metab Pharmacokinet. 2019 Apr;44(2):275-286. doi: 10.1007/s13318-018-0514-6.
7
Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.非 CYP 酶醛氧化酶、羧酸酯酶和 UDP-葡糖醛酸基转移酶的挑战与机遇:重点关注反应表型和人清除率的预测。
AAPS J. 2016 Nov;18(6):1391-1405. doi: 10.1208/s12248-016-9962-6. Epub 2016 Aug 5.
8
Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.评估具有减弱的细胞色素P450活性的大鼠中混合醛氧化酶/细胞色素P450底物的处置情况。
Drug Metab Dispos. 2016 Aug;44(8):1296-303. doi: 10.1124/dmd.115.068338. Epub 2016 Mar 2.